about
sameAs
The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-CoagulantsWarfarine in Unexplained OligohydramniosAnti-Inflammatory and Anti-Coagulant Effects of Salmon Polar LipidsPro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous ThromboembolismStrategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic EventsMedical Need of OAC ReversalExplore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)Management of Direct Oral Anti-Coagulants (DOACs) for Gastrointestinal Endoscopy Procedures
P4844
Q62814330-30909172-F4E2-4AF5-A7DA-EE45B87A6108Q63317415-1FE70317-F8D6-494C-907D-39E2C6FDC421Q63574295-97D9B72E-C974-48E8-98A9-3CCC3E535EE0Q63843774-CEC5887E-BF07-4555-8BFD-7733779E5A61Q65371509-40F6A5F2-5B5E-49CE-BC5B-5D01A17A9A97Q66067598-9298DB71-DB0F-450E-AFF9-FF4E5F85A7C3Q66068732-36C76CD2-6E2A-4FC6-9AFF-FBA315AD9451Q66404007-351EB800-68E3-473B-B1DB-DDED7200F9D7Q66406364-95645502-97BD-46C3-AF24-3F1A3DFCE363
P4844
description
Gatzatze-prozesua azkartzen edo errazten duen substantzia
@eu
agent that causes clotting
@en
substância que produz coagulação em outra
@pt
name
coagulant
@en
coagulante
@es
coagulante
@pt
gatzatzaile
@eu
type
label
coagulant
@en
coagulante
@es
coagulante
@pt
gatzatzaile
@eu
altLabel
Coagulants
@en
koagulatzaile
@eu
prefLabel
coagulant
@en
coagulante
@es
coagulante
@pt
gatzatzaile
@eu
P486
P4746
P486
P672
D27.505.954.502.270